In vivo administration of granulocyte colony-stimulating factor restores long-term depression in hippocampal slices prepared from transgenic APP/PS1 mice

Journal of Neuroscience Research

Volumn 92, Issue 8, 2014, Pages 975-980

  Song, Shijie ^a,b   Wang, Xinming ^c   Sava, Vasyl ^b   Weeber, Edwin J ^c   Sanchez Ramos, Juan ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Electrophysiology; Hematopoietic growth factor; Neuroplasticity

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; SYNAPTOPHYSIN; AMYLOID PRECURSOR PROTEIN; PRESENILIN 1;

ANIMAL EXPERIMENT; ARTICLE; BONE MARROW TRANSPLANTATION; BRAIN FUNCTION; BRAIN SLICE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; EXCITATORY POSTSYNAPTIC POTENTIAL; FACILITATION; HIPPOCAMPAL CA1 REGION; HIPPOCAMPUS; IN VIVO STUDY; LONG TERM DEPRESSION; LONG TERM POTENTIATION; MOUSE; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PATIENT HISTORY OF BONE MARROW TRANSPLANTATION; PRESYNAPTIC NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; SIGNAL TRANSDUCTION; SPATIAL LEARNING; STRATUM RADIATUM; SYNAPTIC TRANSMISSION; SYNAPTOGENESIS; ALZHEIMER DISEASE; ANIMAL; DISEASE MODEL; DRUG EFFECTS; ELECTROPHYSIOLOGY; GENETICS; PATHOPHYSIOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; DISEASE MODELS, ANIMAL; ELECTROPHYSIOLOGY; GRANULOCYTE COLONY-STIMULATING FACTOR; HIPPOCAMPUS; LONG-TERM POTENTIATION; LONG-TERM SYNAPTIC DEPRESSION; MICE; MICE, TRANSGENIC; PRESENILIN-1;

EID: 84902551590     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23378     Document Type: Article

References (21)

1. Cooke SF, Bliss TV. 2006. Plasticity in the human central nervous system. Brain 129:1659-1673.
2. Diederich K, Sevimli S, Dorr H, Kosters E, Hoppen M, Lewejohann L, Klocke R, Minnerup J, Knecht S, Nikol S, Sachser N, Schneider A, Gorji A, Sommer C, Schabitz WR. 2009. The role of granulocyte-colony stimulating factor (G-CSF) in the healthy brain: a characterization of G-CSF-deficient mice. J Neurosci 29:11572-11581.
3. Fitzjohn SM, Morton RA, Kuenzi F, Rosahl TW, Shearman M, Lewis H, Smith D, Reynolds DS, Davies CH, Collingridge GL, Seabrook GR. 2001. Age-related impairment of synaptic transmission but normal long-term potentiation in transgenic mice that overexpress the human APP695SWE mutant form of amyloid precursor protein. J Neurosci 21:4691-4698.
4. Hartung T. 1998. Anti-inflammatory effects of granulocyte colony-stimulating factor. Curr Opin Hematol 5:221-225.
5. Ishida A, Furukawa K, Keller JN, Mattson MP. 1997. Secreted form of beta-amyloid precursor protein shifts the frequency dependency for induction of LTD, and enhances LTP in hippocampal slices. Neuroreport 8:2133-2137.
6. Kawada H, Takizawa S, Takanashi T, Morita Y, Fujita J, Fukuda K, Takagi S, Okano H, Ando K, Hotta T. 2006. Administration of hematopoietic cytokines in the subacute phase after cerebral infarction is effective for functional recovery facilitating proliferation of intrinsic neural stem/progenitor cells and transition of bone marrow-derived neuronal cells. Circulation 113:701-710.
7. Koudinov A, Berezov T, Koudinova N. 2001. Amyloid plaque (and not diffuse amyloid) is a condition for neuronal dysfunction. Clinmed/2001110002v1.
8. Li S, Hong S, Shepardson NE, Walsh DM, Shankar GM, Selkoe D. 2009. Soluble oligomers of amyloid beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron 62:788-801.
9. Lu CZ, Xiao BG. 2007. Neuroprotection of G-CSF in cerebral ischemia. Front Biosci 12:2869-2875.
10. Malenka RC, Bear MF. 2004. LTP and LTD: An embarrassment of riches. Neuron 44:5-21.
11. McHugh TJ, Blum KI, Tsien JZ, Tonegawa S, Wilson MA. 1996. Impaired hippocampal representation of space in CA1-specific NMDAR1 knockout mice. Cell 87:1339-1349.
12. Min SS, Quan HY, Ma J, Lee KH, Back SK, Na HS, Han SH, Yee J-Y, Kim C, Han J-S, Seol GH. 2009. Impairment of long-term depression induced by chronic brain inflammation in rats. Biochem Biophys Res Commun 383:93-97.
13. Purves D. 2008. Neuroscience. Sunderland, MA: Sinauer.
14. Rowan MJ, Klyubin I, Cullen WK, Anwyl R. 2003. Synaptic plasticity in animal models of early Alzheimer's disease. Philos Trans R Soc Lond B Biol Sci 358:821-828.
15. Sanchez-Ramos J, Cimino C, Avila R, Rowe A, Chen R, Whelan G, Lin X, Cao C, Ashok R. 2012. Pilot study of granulocyte-colony stimulating factor for treatment of Alzheimer's disease. J Alzheimers Dis 31:843-855.
16. Sanchez-Ramos J, Song S, Sava V, Catlow B, Lin X, Mori T, Cao C, Arendash GW. 2009. Granulocyte colony stimulating factor decreases brain amyloid burden and reverses cognitive impairment in Alzheimer's mice. Neuroscience 163:55-72.
17. Schabitz WR, Schneider A. 2007. New targets for established proteins: exploring G-CSF for the treatment of stroke. Trends Pharmacol Sci 28:157-161.
18. Schneider A, Kruger C, Steigleder T, Weber D, Pitzer C, Laage R, Aronowski J, Maurer MH, Gassler N, Mier W, Hasselblatt M, Kollmar R, Schwab S, Sommer C, Bach A, Kuhn HG, Schabitz WR. 2005. The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest 115:2083-2098.
19. Schneider A, Kuhn HG, Schabitz WR. 2005. A role for G-CSF (granulocyte-colony stimulating factor) in the central nervous system. Cell Cycle 4:1753-1757.
20. Tigue CC, McKoy JM, Evens AM, Trifilio SM, Tallman MS, Bennett CL. 2007. Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project. Bone Marrow Transplant 40:185-192.
21. Weeber EJ, Beffert U, Jones C, Christian JM, Forster E, Sweatt JD, Herz J. 2002. Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning. J Biol Chem 277:39944-39952.